These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 15208227)
1. Limited usefulness of initial blood cultures in community acquired pneumonia. Corbo J; Friedman B; Bijur P; Gallagher EJ Emerg Med J; 2004 Jul; 21(4):446-8. PubMed ID: 15208227 [TBL] [Abstract][Full Text] [Related]
2. [Clinical usefulness of blood cultures in hospitalized patients with community-acquired pneumonia]. Díaz A; Calvo M; O'Brien A; Farías G; Mardónez JM; Saldías F Rev Med Chil; 2002 Sep; 130(9):993-1000. PubMed ID: 12434646 [TBL] [Abstract][Full Text] [Related]
3. The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures. Waterer GW; Wunderink RG Respir Med; 2001 Jan; 95(1):78-82. PubMed ID: 11207022 [TBL] [Abstract][Full Text] [Related]
4. Blood cultures do not change management in hospitalized patients with community-acquired pneumonia. Ramanujam P; Rathlev NK Acad Emerg Med; 2006 Jul; 13(7):740-5. PubMed ID: 16766742 [TBL] [Abstract][Full Text] [Related]
5. An emergency department-based randomized trial of nonbronchoscopic bronchoalveolar lavage for early pathogen identification in severe community-acquired pneumonia. Rodriguez RM; Fancher ML; Phelps M; Hawkins K; Johnson J; Stacks K; Rossini T; Way M; Holland D Ann Emerg Med; 2001 Oct; 38(4):357-63. PubMed ID: 11574790 [TBL] [Abstract][Full Text] [Related]
6. [Diagnosis and ambulatory treatment of patients with community-acquired pneumonia: variability of complementary tests and study of the effectiveness of roxithromycin. Study Group on Ambulatory Treatment of Community-Acquired Pneumonia (NACTA)]. Rev Clin Esp; 1999 Nov; 199(11):700-4. PubMed ID: 10638232 [TBL] [Abstract][Full Text] [Related]
7. Selective use of blood cultures in emergency department pneumonia patients. Benenson RS; Kepner AM; Pyle DN; Cavanaugh S J Emerg Med; 2007 Jul; 33(1):1-8. PubMed ID: 17630066 [TBL] [Abstract][Full Text] [Related]
8. Predicting bacteremic pneumonia in HIV-1-infected patients consulting the ED. Perelló R; Miró O; Marcos MA; Almela M; Bragulat E; Sánchez M; Agustí C; Miro JM; Moreno A Am J Emerg Med; 2010 May; 28(4):454-9. PubMed ID: 20466225 [TBL] [Abstract][Full Text] [Related]
10. Severity scoring in community-acquired pneumonia caused by Streptococcus pneumoniae: a 5-year experience. Ioachimescu OC; Ioachimescu AG; Iannini PB Int J Antimicrob Agents; 2004 Nov; 24(5):485-90. PubMed ID: 15519482 [TBL] [Abstract][Full Text] [Related]
11. The impact on community acquired pneumonia empirical therapy of diagnostic bronchoscopic techniques. Manali E; Papadopoulos A; Tsiodras S; Polychronopoulos V; Giamarellou H; Kanellakopoulou K Scand J Infect Dis; 2008; 40(4):286-92. PubMed ID: 17918018 [TBL] [Abstract][Full Text] [Related]
12. C-reactive protein velocity following antibiotics in patients with chronic obstructive pulmonary disease exacerbation and community acquired pneumonia. Justo D; Lachmi S; Saar N; Joffe E; Atzmony L; Mashav N; Henis O; Sade B; Chundadze T; Steinvil A; Paran Y Eur J Intern Med; 2009 Sep; 20(5):518-21. PubMed ID: 19712857 [TBL] [Abstract][Full Text] [Related]
13. Understanding variation in quality of antibiotic use for community-acquired pneumonia: effect of patient, professional and hospital factors. Schouten JA; Hulscher ME; Kullberg BJ; Cox A; Gyssens IC; van der Meer JW; Grol RP J Antimicrob Chemother; 2005 Sep; 56(3):575-82. PubMed ID: 16049096 [TBL] [Abstract][Full Text] [Related]
14. Severe community-acquired pneumonia: an Australian perspective. Wilson PA; Ferguson J Intern Med J; 2005 Dec; 35(12):699-705. PubMed ID: 16313544 [TBL] [Abstract][Full Text] [Related]
15. One drug or two? Step-down therapy after i.v. antibiotics for community-acquired pneumonia. Harrington Z; Barnes DJ Intern Med J; 2007 Nov; 37(11):767-71. PubMed ID: 17908087 [TBL] [Abstract][Full Text] [Related]
16. Utility of Blood Culture Among Children Hospitalized With Community-Acquired Pneumonia. Neuman MI; Hall M; Lipsett SC; Hersh AL; Williams DJ; Gerber JS; Brogan TV; Blaschke AJ; Grijalva CG; Parikh K; Ambroggio L; Shah SS; Pediatrics; 2017 Sep; 140(3):. PubMed ID: 28835382 [TBL] [Abstract][Full Text] [Related]
17. [Clinical predictors of bacteremia in immunocompetent adult patients hospitalized for community-acquired pneumonia]. Saldías P F; Reyes B T; Sáez B J; Rain M C; Illanes C P; Briceño V C; Díaz P O Rev Med Chil; 2015 May; 143(5):553-61. PubMed ID: 26203565 [TBL] [Abstract][Full Text] [Related]
18. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis. Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274 [TBL] [Abstract][Full Text] [Related]
19. Antibiotic timing and errors in diagnosing pneumonia. Welker JA; Huston M; McCue JD Arch Intern Med; 2008 Feb; 168(4):351-6. PubMed ID: 18299488 [TBL] [Abstract][Full Text] [Related]
20. Outpatient treatment of community-acquired pneumonia: evolving trends and a focus on fluoroquinolones. Carrie AG; Kozyrskyj AL Can J Clin Pharmacol; 2006; 13(1):e102-11. PubMed ID: 16585811 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]